FI901876A7 - Epätäydelliset hepadnavirukset, rokotteita tuottavat solulinjat sekä m aksan sairauksien hoito - Google Patents

Epätäydelliset hepadnavirukset, rokotteita tuottavat solulinjat sekä m aksan sairauksien hoito Download PDF

Info

Publication number
FI901876A7
FI901876A7 FI901876A FI901876A FI901876A7 FI 901876 A7 FI901876 A7 FI 901876A7 FI 901876 A FI901876 A FI 901876A FI 901876 A FI901876 A FI 901876A FI 901876 A7 FI901876 A7 FI 901876A7
Authority
FI
Finland
Prior art keywords
hepadnaviruses
vaccine
incomplete
treatment
cell lines
Prior art date
Application number
FI901876A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI901876A0 (fi
Inventor
Arthur Louis Horwich
Jesse William Summers
Original Assignee
Univ Yale
Fox Chase Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale, Fox Chase Cancer Center filed Critical Univ Yale
Publication of FI901876A0 publication Critical patent/FI901876A0/fi
Publication of FI901876A7 publication Critical patent/FI901876A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI901876A 1988-08-16 1989-08-16 Epätäydelliset hepadnavirukset, rokotteita tuottavat solulinjat sekä m aksan sairauksien hoito FI901876A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23281188A 1988-08-16 1988-08-16
PCT/US1989/003521 WO1990002176A1 (en) 1988-08-16 1989-08-16 Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders

Publications (2)

Publication Number Publication Date
FI901876A0 FI901876A0 (fi) 1990-04-12
FI901876A7 true FI901876A7 (fi) 1990-04-12

Family

ID=22874695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901876A FI901876A7 (fi) 1988-08-16 1989-08-16 Epätäydelliset hepadnavirukset, rokotteita tuottavat solulinjat sekä m aksan sairauksien hoito

Country Status (8)

Country Link
EP (1) EP0380656A1 (da)
AU (1) AU4315689A (da)
DK (1) DK93390A (da)
FI (1) FI901876A7 (da)
IE (1) IE892640L (da)
IL (1) IL91335A0 (da)
WO (1) WO1990002176A1 (da)
ZA (1) ZA896246B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610050A (en) * 1990-04-20 1997-03-11 The General Hospital Corporation Methods of preventing viral replication
JPH05506993A (ja) * 1990-04-20 1993-10-14 ザ・ジェネラル・ホスピタル・コーポレーション ウイルスの複製を防止する方法
FR2716459B1 (fr) * 1994-02-22 1996-05-10 Univ Paris Curie Système hôte-vecteur utilisable en thérapie génique.
US5869248A (en) * 1994-03-07 1999-02-09 Yale University Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences
US6057153A (en) * 1995-01-13 2000-05-02 Yale University Stabilized external guide sequences
US5683873A (en) * 1995-01-13 1997-11-04 Innovir Laboratories, Inc. EGS-mediated inactivation of target RNA
DE19517532C2 (de) * 1995-05-12 1999-10-28 Max Planck Gesellschaft HBV-Vektoren und Zellen zu ihrer Bereitstellung
US5980901A (en) * 1996-09-18 1999-11-09 The Board Of Regents Of The University Of Texas System Viral defective interfering particles and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers

Also Published As

Publication number Publication date
DK93390A (da) 1990-06-15
WO1990002176A1 (en) 1990-03-08
IE892640L (en) 1990-02-16
AU4315689A (en) 1990-03-23
EP0380656A1 (en) 1990-08-08
FI901876A0 (fi) 1990-04-12
IL91335A0 (en) 1990-03-19
ZA896246B (en) 1990-06-27
DK93390D0 (da) 1990-04-11

Similar Documents

Publication Publication Date Title
KR910700249A (ko) 신규 치료학적 활성 화합물 및 그의 제조 방법
FI900052A7 (fi) Koostumuksia ja hoitomenetelmiä peräpukamia ja muita varten
DK299087D0 (da) Proteins and derivatives thereof
DK90089A (da) Hudbehandlingspraeparat
FI873905A7 (fi) Terapeuttinen koostumus ja menetelmä.
DK254488A (da) Azaindol- og indolizinderivater
PT87554A (pt) Didinfecting and sterilizing composition
FI880416L (fi) Puun käsittelyseos ja -menetelmä
IT220679Z2 (it) Incastonatura per gioielleria e bigiotteria
DK373688D0 (da) Behandlingsmetode
FR2566662B1 (fr) Association medicamenteuse utilisee en photochimiotherapie
FI894321A7 (fi) Terapeuttisia aineita
FI892341A7 (fi) Propanoliamiinijohdannaisia
ATA120686A (de) Holzbehandlungskammer
NO891715D0 (no) Ekspresjon av interferon-8 i metylotrofe gjaersorter.
DE3791059T1 (de) Zementierverfahren und -anlage
DK85290D0 (da) Terapeutisk virksomme forbindelser
IT8720352A0 (it) Sostanza profilattica e terapeutica per disturbi epatici.
BR8805644A (pt) Conjunto de mao francesa aperfeicoada
FI874643A7 (fi) Terapeuttiset aineet ja niiden käyttö.
DK179288A (da) Dioxolan- og dioxanderivater
FI882289A0 (fi) Anordning foer reglering av effekten i en stroemkrets.
KR890009165U (ko) 가습기 겸용 온장고
SE8504463D0 (sv) Dosier- und appliziervorrichtung
FI913379A7 (fi) Soluterapian geeniproteiinituotteet ja menetelmät

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: FOX CHASE CANCER CENTER

Owner name: YALE UNIVERSITY